LONDON — ORCA Computing has officially unveiled the PT-2, the next-generation system in its PT Series of photonic quantum systems. Building upon the success of the PT-1, which has already been deployed across seven on-premises locations, the PT-2 marks a major milestone in the company’s efforts to revolutionize practical quantum computing.

Designed to align with ORCA’s vision of reshaping quantum computing, the PT-2 delivers a commercially viable solution with seamless integration into high-performance computing (HPC) environments. By incorporating quantum-enhanced machine learning capabilities and leveraging the NVIDIA CUDA-Q development platform, the PT-2 facilitates the integration of quantum computing into generative AI and optimization workflows, positioning it as a key enabler for industrial-scale quantum AI applications. This development signifies a break from the limitations of traditional quantum approaches, enabling organizations to fully embed quantum technology into their AI-driven initiatives.

In another first, ORCA Computing will deploy a pioneering quantum computing testbed for the UK’s National Quantum Computing Centre (NQCC). This testbed, which integrates GPU processing, will serve as a platform to explore a variety of quantum methodologies and their potential applications. By focusing on hybrid quantum/classical neural networks and photonic quantum processors, this initiative aims to accelerate the evolution of photonic quantum architectures, particularly in the realm of machine learning.

“Generative AI has the potential to revolutionize industries, but it’s reaching a critical point of unsustainability,” explained Bob Sorensen, Senior Vice President of Research and Chief Analyst for Quantum Computing at Hyperion Research. “ORCA’s PT-2 addresses key challenges such as power consumption, cost, and model quality. Its quantum-enhanced capabilities provide a more efficient approach, helping to overcome these barriers by offering a more refined distribution for model training.”

ORCA’s groundbreaking photonic technology is already being applied across various industries, including manufacturing, energy, and pharmaceuticals, to address complex computational challenges. For example, in the field of chemical formulation, ORCA’s partners are using machine learning to generate novel molecules. Additionally, in vaccine development, the PT-2 is advancing peptide design through quantum-enhanced generative AI, outperforming conventional methods.

“Harnessing the power of ORCA Computing’s advanced technology, combined with NVIDIA’s robust GPU capabilities, we have created a hybrid quantum-classical infrastructure that demonstrates quantum-enhanced applications across multiple QPUs on the PT Series,” stated Krzysztof Kurowski from the Poznan Supercomputing and Networking Center (PSNC). “We are eager to continue collaborating with ORCA, using PT-1 systems to drive research in areas such as biological imaging.”

Richard Murray, Co-founder and CEO of ORCA Computing, emphasized, “The PT-2 not only represents the next step in quantum technology but also provides users with a seamless pathway to adopt quantum computing without significant additional investments. Our roadmap ensures that our customers will be able to upgrade their systems and benefit from the latest advancements in quantum technologies.”

To learn more, join CEO Richard Murray at the panel “Quantum AI Algorithms and Software Development” at IQT Quantum+AI on October 30, 2024, in New York City. The ORCA Computing team will also be present at the SC24 Supercomputing Conference, scheduled for November 17-22, 2024, at the Georgia World Congress Center in Atlanta.